Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leukemia 2022-04, Vol.36 (4), p.1164-1166
Hauptverfasser: Kopmar, Noam E., Othus, Megan, Gardner, Kelda M., Shaw, Carole, Halpern, Anna B., Scott, Bart L., Hendrie, Paul C., Walter, Roland B., Becker, Pamela S., Estey, Elihu H., Percival, Mary-Elizabeth M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1166
container_issue 4
container_start_page 1164
container_title Leukemia
container_volume 36
creator Kopmar, Noam E.
Othus, Megan
Gardner, Kelda M.
Shaw, Carole
Halpern, Anna B.
Scott, Bart L.
Hendrie, Paul C.
Walter, Roland B.
Becker, Pamela S.
Estey, Elihu H.
Percival, Mary-Elizabeth M.
description
doi_str_mv 10.1038/s41375-022-01509-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2622287095</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2622287095</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-46b6d0983402d48e2cce01d1b66c097ce8db1480f1278295b0dce88ba38714b23</originalsourceid><addsrcrecordid>eNp9kb1uFDEUhS0EIkvgBSiQJRoaw_XveEoUhR8pUhqoLY99d3bCjCfYnmLfHi8biERBZcn3O8dX_gh5zeE9B2k_FMVlpxkIwYBr6Bk8ITuuOsO01vwp2YG1HTO9UBfkRSl3AKeheU4upAZtdW92JN9uNawLFjr4gpGuidaMvi6YKi1Y65RGOiWacZ99qGs-Uh-2inQ54rxOkc64_cBl8tSnlq4HzPQwjQc2Zh8fqcXP05h8ChOWl-TZ3s8FXz2cl-T7p-tvV1_Yze3nr1cfb1iQwlSmzGAi9FYqEFFZFCEg8MgHYwL0XUAbB64s7LnorOj1ALHd2cFL23E1CHlJ3p177_P6c8NS3TKVgPPsE65bccIIIWwHvW7o23_Qu3XLqW3XKGXaDlxCo8SZCnktpf2Iu8_T4vPRcXAnI-5sxDUj7rcRdwq9eajehgXj38gfBQ2QZ6C0URoxP779n9pficOXLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2646834130</pqid></control><display><type>article</type><title>Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Kopmar, Noam E. ; Othus, Megan ; Gardner, Kelda M. ; Shaw, Carole ; Halpern, Anna B. ; Scott, Bart L. ; Hendrie, Paul C. ; Walter, Roland B. ; Becker, Pamela S. ; Estey, Elihu H. ; Percival, Mary-Elizabeth M.</creator><creatorcontrib>Kopmar, Noam E. ; Othus, Megan ; Gardner, Kelda M. ; Shaw, Carole ; Halpern, Anna B. ; Scott, Bart L. ; Hendrie, Paul C. ; Walter, Roland B. ; Becker, Pamela S. ; Estey, Elihu H. ; Percival, Mary-Elizabeth M.</creatorcontrib><identifier>ISSN: 0887-6924</identifier><identifier>EISSN: 1476-5551</identifier><identifier>DOI: 10.1038/s41375-022-01509-0</identifier><identifier>PMID: 35058596</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699/1541/1990/283/1897 ; 692/700/228 ; Acute myeloid leukemia ; Age ; Cancer Research ; Cancer therapies ; Chronic Disease ; Clinical trials ; Community organizations ; Critical Care Medicine ; FDA approval ; Hematology ; Humans ; Intensive ; Internal Medicine ; Letter ; Leukemia ; Leukemia, Myeloid, Acute - drug therapy ; Leukemia, Myeloid, Acute - pathology ; Medical research ; Medicine ; Medicine &amp; Public Health ; Multivariate analysis ; Oncology ; Patients ; Research centers</subject><ispartof>Leukemia, 2022-04, Vol.36 (4), p.1164-1166</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2022</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-46b6d0983402d48e2cce01d1b66c097ce8db1480f1278295b0dce88ba38714b23</cites><orcidid>0000-0002-7016-951X ; 0000-0002-9268-3341 ; 0000-0001-8176-6371 ; 0000-0001-6235-9463</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35058596$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kopmar, Noam E.</creatorcontrib><creatorcontrib>Othus, Megan</creatorcontrib><creatorcontrib>Gardner, Kelda M.</creatorcontrib><creatorcontrib>Shaw, Carole</creatorcontrib><creatorcontrib>Halpern, Anna B.</creatorcontrib><creatorcontrib>Scott, Bart L.</creatorcontrib><creatorcontrib>Hendrie, Paul C.</creatorcontrib><creatorcontrib>Walter, Roland B.</creatorcontrib><creatorcontrib>Becker, Pamela S.</creatorcontrib><creatorcontrib>Estey, Elihu H.</creatorcontrib><creatorcontrib>Percival, Mary-Elizabeth M.</creatorcontrib><title>Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies</title><title>Leukemia</title><addtitle>Leukemia</addtitle><addtitle>Leukemia</addtitle><subject>692/699/1541/1990/283/1897</subject><subject>692/700/228</subject><subject>Acute myeloid leukemia</subject><subject>Age</subject><subject>Cancer Research</subject><subject>Cancer therapies</subject><subject>Chronic Disease</subject><subject>Clinical trials</subject><subject>Community organizations</subject><subject>Critical Care Medicine</subject><subject>FDA approval</subject><subject>Hematology</subject><subject>Humans</subject><subject>Intensive</subject><subject>Internal Medicine</subject><subject>Letter</subject><subject>Leukemia</subject><subject>Leukemia, Myeloid, Acute - drug therapy</subject><subject>Leukemia, Myeloid, Acute - pathology</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Multivariate analysis</subject><subject>Oncology</subject><subject>Patients</subject><subject>Research centers</subject><issn>0887-6924</issn><issn>1476-5551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kb1uFDEUhS0EIkvgBSiQJRoaw_XveEoUhR8pUhqoLY99d3bCjCfYnmLfHi8biERBZcn3O8dX_gh5zeE9B2k_FMVlpxkIwYBr6Bk8ITuuOsO01vwp2YG1HTO9UBfkRSl3AKeheU4upAZtdW92JN9uNawLFjr4gpGuidaMvi6YKi1Y65RGOiWacZ99qGs-Uh-2inQ54rxOkc64_cBl8tSnlq4HzPQwjQc2Zh8fqcXP05h8ChOWl-TZ3s8FXz2cl-T7p-tvV1_Yze3nr1cfb1iQwlSmzGAi9FYqEFFZFCEg8MgHYwL0XUAbB64s7LnorOj1ALHd2cFL23E1CHlJ3p177_P6c8NS3TKVgPPsE65bccIIIWwHvW7o23_Qu3XLqW3XKGXaDlxCo8SZCnktpf2Iu8_T4vPRcXAnI-5sxDUj7rcRdwq9eajehgXj38gfBQ2QZ6C0URoxP779n9pficOXLQ</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Kopmar, Noam E.</creator><creator>Othus, Megan</creator><creator>Gardner, Kelda M.</creator><creator>Shaw, Carole</creator><creator>Halpern, Anna B.</creator><creator>Scott, Bart L.</creator><creator>Hendrie, Paul C.</creator><creator>Walter, Roland B.</creator><creator>Becker, Pamela S.</creator><creator>Estey, Elihu H.</creator><creator>Percival, Mary-Elizabeth M.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7016-951X</orcidid><orcidid>https://orcid.org/0000-0002-9268-3341</orcidid><orcidid>https://orcid.org/0000-0001-8176-6371</orcidid><orcidid>https://orcid.org/0000-0001-6235-9463</orcidid></search><sort><creationdate>20220401</creationdate><title>Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies</title><author>Kopmar, Noam E. ; Othus, Megan ; Gardner, Kelda M. ; Shaw, Carole ; Halpern, Anna B. ; Scott, Bart L. ; Hendrie, Paul C. ; Walter, Roland B. ; Becker, Pamela S. ; Estey, Elihu H. ; Percival, Mary-Elizabeth M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-46b6d0983402d48e2cce01d1b66c097ce8db1480f1278295b0dce88ba38714b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>692/699/1541/1990/283/1897</topic><topic>692/700/228</topic><topic>Acute myeloid leukemia</topic><topic>Age</topic><topic>Cancer Research</topic><topic>Cancer therapies</topic><topic>Chronic Disease</topic><topic>Clinical trials</topic><topic>Community organizations</topic><topic>Critical Care Medicine</topic><topic>FDA approval</topic><topic>Hematology</topic><topic>Humans</topic><topic>Intensive</topic><topic>Internal Medicine</topic><topic>Letter</topic><topic>Leukemia</topic><topic>Leukemia, Myeloid, Acute - drug therapy</topic><topic>Leukemia, Myeloid, Acute - pathology</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Multivariate analysis</topic><topic>Oncology</topic><topic>Patients</topic><topic>Research centers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kopmar, Noam E.</creatorcontrib><creatorcontrib>Othus, Megan</creatorcontrib><creatorcontrib>Gardner, Kelda M.</creatorcontrib><creatorcontrib>Shaw, Carole</creatorcontrib><creatorcontrib>Halpern, Anna B.</creatorcontrib><creatorcontrib>Scott, Bart L.</creatorcontrib><creatorcontrib>Hendrie, Paul C.</creatorcontrib><creatorcontrib>Walter, Roland B.</creatorcontrib><creatorcontrib>Becker, Pamela S.</creatorcontrib><creatorcontrib>Estey, Elihu H.</creatorcontrib><creatorcontrib>Percival, Mary-Elizabeth M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kopmar, Noam E.</au><au>Othus, Megan</au><au>Gardner, Kelda M.</au><au>Shaw, Carole</au><au>Halpern, Anna B.</au><au>Scott, Bart L.</au><au>Hendrie, Paul C.</au><au>Walter, Roland B.</au><au>Becker, Pamela S.</au><au>Estey, Elihu H.</au><au>Percival, Mary-Elizabeth M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies</atitle><jtitle>Leukemia</jtitle><stitle>Leukemia</stitle><addtitle>Leukemia</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>36</volume><issue>4</issue><spage>1164</spage><epage>1166</epage><pages>1164-1166</pages><issn>0887-6924</issn><eissn>1476-5551</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>35058596</pmid><doi>10.1038/s41375-022-01509-0</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-7016-951X</orcidid><orcidid>https://orcid.org/0000-0002-9268-3341</orcidid><orcidid>https://orcid.org/0000-0001-8176-6371</orcidid><orcidid>https://orcid.org/0000-0001-6235-9463</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0887-6924
ispartof Leukemia, 2022-04, Vol.36 (4), p.1164-1166
issn 0887-6924
1476-5551
language eng
recordid cdi_proquest_miscellaneous_2622287095
source MEDLINE; Alma/SFX Local Collection
subjects 692/699/1541/1990/283/1897
692/700/228
Acute myeloid leukemia
Age
Cancer Research
Cancer therapies
Chronic Disease
Clinical trials
Community organizations
Critical Care Medicine
FDA approval
Hematology
Humans
Intensive
Internal Medicine
Letter
Leukemia
Leukemia, Myeloid, Acute - drug therapy
Leukemia, Myeloid, Acute - pathology
Medical research
Medicine
Medicine & Public Health
Multivariate analysis
Oncology
Patients
Research centers
title Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T13%3A39%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20based%20on%20treatment%20setting%20in%20refractory%20acute%20myeloid%20leukemia%20and%20other%20high-grade%20myeloid%20malignancies&rft.jtitle=Leukemia&rft.au=Kopmar,%20Noam%20E.&rft.date=2022-04-01&rft.volume=36&rft.issue=4&rft.spage=1164&rft.epage=1166&rft.pages=1164-1166&rft.issn=0887-6924&rft.eissn=1476-5551&rft_id=info:doi/10.1038/s41375-022-01509-0&rft_dat=%3Cproquest_cross%3E2622287095%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2646834130&rft_id=info:pmid/35058596&rfr_iscdi=true